
THINK Surgical entered into a debt facility with Symbiotic Capital which will provide up to $65 million of growth capital. The facility provided an initial funded tranche of $25 million, with an additional $15 million based on achievement of certain milestones, and up to $25 million of discretionary capital.
Proceeds will be used by THINK to continue to advance its dual channel commercial strategy for its TMINI Miniature Robotic System, which is currently compatible with approximately 70% of the market share for total knee implants.
Stuart Simpson, President, and Chief Executive Officer of THINK Surgical said, “This facility, combined with recent additional investments by our existing investors, will allow us to continue our significant growth and development of TMINI, and is expected to fully finance the company to profitability.”
Source: THINK Surgical, Inc.
THINK Surgical entered into a debt facility with Symbiotic Capital which will provide up to $65 million of growth capital. The facility provided an initial funded tranche of $25 million, with an additional $15 million based on achievement of certain milestones, and up to $25 million of discretionary capital.
Proceeds will be used by THINK to...
THINK Surgical entered into a debt facility with Symbiotic Capital which will provide up to $65 million of growth capital. The facility provided an initial funded tranche of $25 million, with an additional $15 million based on achievement of certain milestones, and up to $25 million of discretionary capital.
Proceeds will be used by THINK to continue to advance its dual channel commercial strategy for its TMINI Miniature Robotic System, which is currently compatible with approximately 70% of the market share for total knee implants.
Stuart Simpson, President, and Chief Executive Officer of THINK Surgical said, “This facility, combined with recent additional investments by our existing investors, will allow us to continue our significant growth and development of TMINI, and is expected to fully finance the company to profitability.”
Source: THINK Surgical, Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





